Advertisement
Journal Home
Search for

Volume 45, Issue 17, Pages 2977-2983 (November 2009)


View previous. 10 of 27 View next.

Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer

J. Dauplata, G. CheneabCorresponding Author Informationemail address, C. Pomela, M.M. Dauplatcd, G.Le Bouëdeca, F. Mishellanyc, N. Lagardec, Y.J. Bignone, P. Jaffeuxf, B. Aublet-Cuvelierf, P. Dechelotted, J.L. Poulyg, F. Penault-Llorcac

Received 18 April 2009; received in revised form 9 June 2009; accepted 12 June 2009. published online 12 October 2009.

Abstract 

Aim

Ovarian epithelial dysplasia (OED) was first described after prophylactic oophorectomy for genetic risk of ovarian cancer. In light of Fathalla’s incessant ovulation theory, this study was set up to describe the presence of ovarian abnormalities (dysplasia) after ovulation induction and to compare dysplasia profiles in stimulated and genetic risk ovaries.

Methods

One-hundred and twenty-four patients who had undergone salpingo-oophorectomies or ovarian cystectomies between 1990 and 2005 were reviewed. They were divided into three groups: (1) previous in vitro fertilisation (n=35); (2) prophylactic oophorectomies for genetic risk (n=27) and (3) fertile non-cancerous controls (n=62). Eleven cytological and architectural epithelial features were defined and a dysplasia score was calculated to quantify ovarian epithelial abnormalities.

Results

Mean dysplasia score was significantly higher in the genetic risk and stimulated ovary groups than in controls (9.55 versus 3.62, p<0.0001; 7.51 versus 3.62, p<0.0002, respectively). Cytological and architectural abnormalities were more frequent in the genetic risk group, while the profile of abnormalities was different in the genetic risk and stimulated groups.

Conclusions

These findings support a possible relationship between OED and the use of ovulation-stimulating drugs. The increased dysplasia score in stimulated and genetic risk ovaries might be consistent with progression towards neoplastic transformation, and may justify the use of the term dysplasia or intraepithelial ovarian neoplasia. The observation of dysplasia in the stimulated group may differentiate women at risk. Conversely, the fact that the dysplasia profile after stimulation differs from that in genetic risk ovaries suggests that ovarian stimulation may predispose to a different evolution.

a Department of Surgery, Centre Jean Perrin, Clermont-Ferrand, France

b Department of Obstetrics, Gynaecology and Reproductive Medicine, CHU St. Etienne, France

c Department of Histopathology, Centre Jean Perrin, Clermont-Ferrand, France

d Department of Histopathology, CHU Clermont-Ferrand, France

e Department of Molecular Oncology, Centre Jean Perrin, Clermont-Ferrand, France

f Department of Medical Information, CHU Clermont-Ferrand, France

g Department of Obstetrics, Gynaecology and Reproductive Medicine, CHU Clermont-Ferrand, France

Corresponding Author InformationCorresponding author: Address: Department of Surgery, Centre Jean Perrin, Clermont-Ferrand, France. Tel.: +33 6 07 08 17 86; fax: +33 4 77 82 89 56.

PII: S0959-8049(09)00458-4

doi:10.1016/j.ejca.2009.06.012


View previous. 10 of 27 View next.